Antibiotic News and Research

RSS
PolyMedix presents data on PMX-60056 Phase 1B/2 studies for blood clotting at American Heart Association

PolyMedix presents data on PMX-60056 Phase 1B/2 studies for blood clotting at American Heart Association

ViroPharma presents data on Cinryze C1 esterase inhibitor for HAE at ACAAI Meeting

ViroPharma presents data on Cinryze C1 esterase inhibitor for HAE at ACAAI Meeting

Deinobiotics project receives €1.35 million for developing novel antibiotic, antifungal compounds

Deinobiotics project receives €1.35 million for developing novel antibiotic, antifungal compounds

Report documents increase in R&D projects on developing world diseases

Report documents increase in R&D projects on developing world diseases

Research on E.Coli bacteria could help develop new vaccine for urinary tract infection

Research on E.Coli bacteria could help develop new vaccine for urinary tract infection

Targeted Genetics enters definitive agreements to acquire Biocontrol

Targeted Genetics enters definitive agreements to acquire Biocontrol

NovaBay third quarter net loss increases to $1.6 million

NovaBay third quarter net loss increases to $1.6 million

Aradigm reports $1.3M net income for third quarter 2010 vs. $3.0M net loss for third quarter 2009

Aradigm reports $1.3M net income for third quarter 2010 vs. $3.0M net loss for third quarter 2009

MqsA and MqsR protein complex can disrupt drug-resistant biofilm formation

MqsA and MqsR protein complex can disrupt drug-resistant biofilm formation

PolyMedix receives FDA regulatory clearance for PMX-30063 IND application

PolyMedix receives FDA regulatory clearance for PMX-30063 IND application

PolyMedix announces publication of defensin-mimetic compounds in Molecular Oral Microbiology

PolyMedix announces publication of defensin-mimetic compounds in Molecular Oral Microbiology

Priaxon and Technical University Munich partner to develop anti-infective agents against infectious diseases

Priaxon and Technical University Munich partner to develop anti-infective agents against infectious diseases

EUSA completes BLA filing for ERWINASE in treatment of acute lymphoblastic leukemia

EUSA completes BLA filing for ERWINASE in treatment of acute lymphoblastic leukemia

GBS meningitis in infants still very serious

GBS meningitis in infants still very serious

NovaBay receives $244,479 QTDP grant for program to treat Impetigo

NovaBay receives $244,479 QTDP grant for program to treat Impetigo

TB Alliance launches three-drug combination trial for drug-sensitive and multidrug-resistant TB

TB Alliance launches three-drug combination trial for drug-sensitive and multidrug-resistant TB

Study suggests bacterial products contribute to autoimmune diseases

Study suggests bacterial products contribute to autoimmune diseases

AHRQ grants $34 million to prevent healthcare-associated infections

AHRQ grants $34 million to prevent healthcare-associated infections

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

Advanced Life Sciences awarded $244,479.25 grant under Qualifying Therapeutic Discovery Project

Advanced Life Sciences awarded $244,479.25 grant under Qualifying Therapeutic Discovery Project

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.